Clinical trial Recruiting at 3 sites Phase 2 Interventional Ages 18 to 75

Cerebello-spinal direct current stimulation to improve walking in chronic stroke

Official title: Efficacy of Cerebello-spinal Direct Current Stimulation on Functional Mobility in Chronic Stroke Patients

Run by Universidade Federal de Pernambuco · NCT07073287 · Data updated 2026-11-12

Test whether cerebello-spinal direct current stimulation combined with daily treadmill training improves walking and mobility in people who had a stroke at least six months ago.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment30 (estimated)
SponsorUniversidade Federal de Pernambuco
Academic / other
Locations3 sites (João Pessoa, Paraíba and 2 other locations)
StatusRecruiting
StartedMay 1, 2024
Main results expectedJanuary 1, 2026
Study endsAugust 1, 2026
Registry record updatedJuly 18, 2025
Trial IDNCT07073287 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults at least six months after a stroke who have measurable gait impairment and can communicate, without metallic spinal implants or major orthopedic/rheumatologic conditions, are the intended participants.

Probably not a fit

People with metallic spinal implants, major orthopedic or rheumatologic disorders that limit walking, inability to communicate, or those in the acute phase of stroke (<6 months) are unlikely to benefit or may be ineligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, sham-controlled Phase 2 trial delivers cerebello-spinal direct current stimulation (csDCS) together with daily treadmill training for two weeks in people with chronic stroke and gait impairment. Participants are assigned to active csDCS plus treadmill training or a sham procedure plus the same treadmill training, with assessments before, after, and at follow-up. Primary outcomes focus on gait measures and overall functional mobility, and safety and side effects are recorded throughout the study. Eligible participants are adults at least six months post-stroke without metallic spinal implants or major orthopedic/rheumatologic disorders.

Why it matters

Potential benefit: If successful, the approach could improve walking ability and functional mobility for people living with chronic stroke-related gait problems.

How similar studies have gone: Noninvasive brain and spinal stimulation techniques such as transcranial direct current stimulation have shown modest benefits in small post-stroke motor recovery trials, but cerebello-spinal DCS specifically is relatively novel with limited prior data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Confirmation of Stroke by digital or physical imaging or medical report
* Gait impairment
* Stroke with at least 6 months after ictus

Exclusion Criteria:

* Metallic implants in spinal cord
* Major orthopedic/rheumatological disorders
* Inability of verbal or non-verbal communication

Where it's running

  • Federal University of Paraiba
    João Pessoa, Paraíba, Brazil
    Recruiting
  • Federal University of Pernambuco
    Recife, Pernambuco, Brazil
    Recruiting
  • Federal University of Rio de Janeiro
    Rio de Janeiro, Rio de Janeiro, Brazil
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.